Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia

Por Thompson, Andrew B., Ross, Douglas A., Berard, Paul, Figueroa-Bodine, Jaszmin, Livada, Nancy, Richer, Sara L.
Publicado em 2014